KLOFIT®

| Each tablet contain 50mg of clomifene citrate, №24

 

PHARMACOLOGIC PROPERTIES

АТC code: G03BG02, Ovulation stimulants, synthetic

The ovulatory response to cyclic KLOFIT therapy is mediated through increased output of pituitary gonadotropins by binding to oestrogen receptors in the hypothalamus, which in turn stimulates the maturation and endocrine activity of the ovarian follicle.

Clomifene citrate is a non-steroidal agent which stimulates ovulation in a high percentage of appropriately selected anovulatory women.

 

THERAPEUTIC INDICATIONS

KLOFIT is indicated for the treatment of ovulatory failure in women desiring pregnancy. KLOFIT is indicated only for patients in whom ovulatory dysfunction is demonstrated.

 

© Copyright 2020 GrandMedical Group®. All rights reserved.